RI
RTW Investments Portfolio holdings
AUM
$7.02B
1-Year Return
28.16%
This Quarter Return
+23.39%
1 Year Return
+28.16%
3 Year Return
+245.48%
5 Year Return
+425.65%
10 Year Return
+5,642.23%
AUM
$1.47B
AUM Growth
+$376M
(+35%)
Cap. Flow
+$154M
Cap. Flow
% of AUM
10.53%
Top 10 Holdings %
Top 10 Hldgs %
58.22%
Holding
54
New
7
Increased
25
Reduced
10
Closed
3
Top Buys
| 1 |
ProQR Therapeutics
PRQR
|
$45.4M |
| 2 |
Alnylam Pharmaceuticals
ALNY
|
$37M |
| 3 |
Bristol-Myers Squibb
BMY
|
$27.4M |
| 4 |
PTC Therapeutics
PTCT
|
$22.3M |
| 5 |
MYOK
MyoKardia, Inc. Common Stock
MYOK
|
$21.4M |
Top Sells
| 1 |
Arrowhead Research
ARWR
|
$69.5M |
| 2 |
Regenxbio
RGNX
|
$34.3M |
| 3 |
uniQure
QURE
|
$18.4M |
| 4 |
SAGE
Sage Therapeutics
SAGE
|
$15.9M |
| 5 |
Assembly Biosciences
ASMB
|
$15.5M |
Sector Composition
| 1 | Healthcare | 91.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
SAGE
51
DELISTED
Sage Therapeutics
SAGE
| – | – |
-165,990
| Closed | -$15.9M |
|
52
Catheter Precision
VTAK
$3.12M
| – | – |
0
| – | -$487K |
|
|
KA
53
DELISTED
Kineta, Inc. Common Stock
KA
| – | – |
-2,239
| Closed | -$1.02M |
|